VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce that the TSXV has granted the Company a 30-day extension with respect to its non-brokered private placement financing (the “Offering”), […]
Oil prices top $100 as market braces for long conflict
...
Read moreDetails
